ANALYSIS OF COLORECTAL-CANCER BY COMPARATIVE GENOMIC HYBRIDIZATION - EVIDENCE FOR INDUCTION OF THE METASTATIC PHENOTYPE BY LOSS OF TUMOR-SUPPRESSOR GENES
A. Paredeszaglul et al., ANALYSIS OF COLORECTAL-CANCER BY COMPARATIVE GENOMIC HYBRIDIZATION - EVIDENCE FOR INDUCTION OF THE METASTATIC PHENOTYPE BY LOSS OF TUMOR-SUPPRESSOR GENES, Clinical cancer research, 4(4), 1998, pp. 879-886
Current models suggest that colon cancer initiation and progression ar
e secondary to both the activation of oncogenes and the deletion of tu
mor suppressor genes. The role of each, however, is still poorly under
stood, particularly with regard to the induction of metastasis. We hyp
othesized that genetic differences exist between tumors that metastasi
ze distantly and those that do not, and that oncogenes and tumor suppr
essor genes participate equally in this process. To address this hypot
hesis, human tumor specimens from localized [tumor-node-metastasis (TN
M) stage I-III] and primary colon cancers (n = 10) were directly compa
red with metastatic (TNM stage IV) lesions (ii = 10) using comparative
genomic hybridization analysis. Although several alterations were sha
red equally between primary tumors and metastases (+7q, +19q, and +20q
), two patterns of distinguishing alterations were observed: (a) alter
ations that were more extensive in Liver metastases than in primary tu
mors (+8q, +13q, -4p, -8p, -15q, -17p, -18q, -21q, and -22q); and (b)
alterations that were unique to metastatic lesions (-9q, -11q, and -17
q). Overall, genetic losses were more common than gains, and, more imp
ortantly, the number of losses/tumor was significantly higher for meta
stases than for primary tumors (9.3 + 1.3 versus 4.1 + 0.7; P = 0.0006
2, Wilcoxon's rank-sum test). The distinct predominance of genetic los
ses in the metastatic lesions when compared with the primary localized
tumors provides evidence that the metastatic phenotype is induced by
the deletion of tumor suppressor genes and permits the construction of
physical maps targeting regions where novel tumor suppressor genes ar
e likely to exist.